Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
 Index 
 Full text 
Verbatim report of proceedings
Tuesday, 19 May 2015 - Strasbourg Revised edition

Safer healthcare in Europe (A8-0142/2015 - Piernicola Pedicini)
MPphoto
 
 

  Kay Swinburne (ECR), in writing. ‒ I welcome a large number of the recommendations made in this report to improve patient safety and address the crucial issue of AMR.

In particular, the need for a greater emphasis on training all staff in infection prevention and control highlighted in this report: a comprehensive and team approach will ensure consistent good practices in infection prevention and control are present throughout our healthcare systems.

The report also rightly emphasises the growing gap between increasing antimicrobial resistance and the development of new antibiotics. I welcome calls to accelerate R&D activities in the field of antimicrobial medicines and to create greater incentives for public and private sector collaboration.

Finally, the ʽOne Healthʼ approach to AMR is essential given that our human and animal health systems are interconnected and tackling AMR requires a cross-sector approach, with policies developed accordingly. We must however ensure that any future action to address the risks of AMR developing in animals is based on sound scientific evidence and expert advice.

 
Legal notice - Privacy policy